Utility of Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures.
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2018
At a glance
- Drugs Fosphenytoin (Primary) ; Lacosamide (Primary)
- Indications Seizures
- Focus Therapeutic Use
- Acronyms TRENdS
- 07 May 2018 Status changed to discontinued, as per the results published in the Annals of Neurology
- 07 May 2018 Primary endpoint (Percentage of subjects who experience no NCSs for 24 hours following treatment with LCM vs. fPHT, as measured by continuous) has been met, as per the results published in the Annals of Neurology.
- 07 May 2018 Results published in the Annals of Neurology